Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atherogenics Inc (AGIX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Atherogenics Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1107601.
Total stock buying since 2005: $22,677,564.
Total stock sales since 2005: $7,949,201.
Total stock option exercises since 2005: $535,875.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 26,000 | $910 | 0 | $0 |
| 2008 | 75,000 | $41,750 | 103,386 | $7,620 | 0 | $0 |
| 2007 | 36,000 | $99,576 | 2,132,070 | $1,260,365 | 57,000 | $20,060 |
| 2006 | 669,000 | $11,142,701 | 41,800 | $640,041 | 48,100 | $369,471 |
| 2005 | 749,900 | $11,393,537 | 295,000 | $6,040,265 | 116,100 | $146,344 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-02 | 0 | $0 | 26,000 | $910 | 0 | $0 |
| 2008-10 | 0 | $0 | 100,000 | $6,300 | 0 | $0 |
| 2008-02 | 50,000 | $32,000 | 0 | $0 | 0 | $0 |
| 2008-01 | 25,000 | $9,750 | 3,386 | $1,320 | 0 | $0 |
| 2007-12 | 0 | $0 | 113,562 | $47,608 | 0 | $0 |
| 2007-11 | 0 | $0 | 1,962,990 | $1,093,394 | 0 | $0 |
| 2007-08 | 0 | $0 | 55,518 | $119,363 | 10,000 | $3,000 |
| 2007-06 | 0 | $0 | 0 | $0 | 10,000 | $3,000 |
| 2007-04 | 36,000 | $99,576 | 0 | $0 | 0 | $0 |
| 2007-03 | 0 | $0 | 0 | $0 | 25,000 | $9,500 |
| 2007-01 | 0 | $0 | 0 | $0 | 12,000 | $4,560 |
| 2006-08 | 1,000 | $14,115 | 0 | $0 | 0 | $0 |
| 2006-06 | 40,000 | $520,421 | 0 | $0 | 0 | $0 |
| 2006-05 | 24,000 | $330,998 | 0 | $0 | 0 | $0 |
| 2006-04 | 3,000 | $42,090 | 0 | $0 | 48,100 | $369,471 |
| 2006-03 | 1,000 | $15,827 | 41,800 | $640,041 | 0 | $0 |
| 2006-02 | 225,000 | $3,876,750 | 0 | $0 | 0 | $0 |
| 2006-01 | 375,000 | $6,342,500 | 0 | $0 | 0 | $0 |
| 2005-12 | 0 | $0 | 295,000 | $6,040,265 | 116,100 | $146,344 |
| 2005-10 | 250,000 | $3,887,000 | 0 | $0 | 0 | $0 |
| 2005-06 | 200,000 | $3,196,500 | 0 | $0 | 0 | $0 |
| 2005-05 | 299,900 | $4,310,037 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-02-04 | Barker Sam L (Director) | Sale | 26,000 | .04 | 910 |
| 2008-10-31 | Henos Michael A (Director) | Sale | 100,000 | .06 | 6,300 |
| 2008-02-08 | Bryson Vaughn D (Director) | Buy | 50,000 | .64 | 32,000 |
| 2008-01-25 | Barker Sam L (Director) | Buy | 25,000 | .39 | 9,750 |
| 2008-01-22 | Bryson Vaughn D (Director) | Sale | 3,386 | .39 | 1,320 |
| 2007-12-28 | Bryson Vaughn D (Director) | Sale | 24,733 | .38 | 9,448 |
| 2007-12-27 | Bryson Vaughn D (Director) | Sale | 48,732 | .40 | 19,492 |
| 2007-12-26 | Bryson Vaughn D (Director) | Sale | 2,440 | .40 | 976 |
| 2007-12-20 | Bryson Vaughn D (Director) | Sale | 7,657 | .43 | 3,292 |
| 2007-12-06 | Henos Michael A (Director) | Sale | 30,000 | .48 | 14,400 |
| 2007-11-28 | Barakett Timothy R (10% Owner) | Sale | 1,679,949 | .54 | 908,852 |
| 2007-11-27 | Barakett Timothy R (10% Owner) | Sale | 283,041 | .65 | 184,542 |
| 2007-08-29 | Bryson Vaughn D (Director) | Sale | 55,518 | 2.15 | 119,363 |
| 2007-08-01 | Medford Russell M (President & CEO) | Option Ex | 10,000 | .30 | 3,000 |
| 2007-06-05 | Medford Russell M (President & CEO) | Option Ex | 10,000 | .30 | 3,000 |
| 2007-04-02 | Scott Robert A (Exec VP Research & Development) | Buy | 36,000 | 2.77 | 99,576 |
| 2007-03-20 | Colonnese Mark P (Exec VP, Commercial Operations) | Option Ex | 25,000 | .38 | 9,500 |
| 2007-01-19 | Dagi T. Forcht (Director) | Option Ex | 12,000 | .38 | 4,560 |
| 2006-08-31 | Barker Samuel L (Director) | Buy | 1,000 | 14.12 | 14,115 |
| 2006-06-30 | Bryson Vaughn D (Director) | Buy | 17,132 | 13.06 | 223,778 |
| 2006-06-29 | Bryson Vaughn D (Director) | Buy | 22,868 | 12.97 | 296,643 |
| 2006-05-30 | Bryson Vaughn D (Director) | Buy | 20,000 | 13.87 | 277,460 |
| 2006-05-24 | Pappas Arthur M (Director) | Buy | 1,000 | 12.97 | 12,969 |
| 2006-05-22 | Pappas Arthur M (Director) | Buy | 3,000 | 13.52 | 40,569 |
| 2006-04-27 | Bearman David (Director) | Option Ex | 45,600 | 8.09 | 368,721 |
| 2006-04-27 | Pappas Arthur M (Director) | Buy | 3,000 | 14.03 | 42,090 |
| 2006-04-12 | Medford Russell M (President & CEO) | Option Ex | 2,500 | .30 | 750 |
| 2006-03-24 | Pappas Arthur M (Director) | Buy | 1,000 | 15.83 | 15,827 |
| 2006-03-16 | Scott William A (Director) | Sale | 41,800 | 15.31 | 640,041 |
| 2006-02-01 | Barakett Timothy R (10% Owner) | Buy | 225,000 | 17.23 | 3,876,750 |
| 2006-01-31 | Barakett Timothy R (10% Owner) | Buy | 250,000 | 16.94 | 4,235,000 |
| 2006-01-30 | Barakett Timothy R (10% Owner) | Buy | 125,000 | 16.86 | 2,107,500 |
| 2005-12-28 | Scott Robert A (Sr VP Clinical Dev &) | Sale | 20,000 | 20.01 | 400,140 |
| 2005-12-28 | Scott Robert A (Sr VP Clinical Dev &) | Option Ex | 16,100 | 7.04 | 113,344 |
| 2005-12-28 | Medford Russell M (President & CEO) | Sale | 150,000 | 20.02 | 3,003,000 |
| 2005-12-28 | Alexander R Wayne (Director) | Sale | 25,000 | 20.09 | 502,125 |
| 2005-12-27 | Colonnese Mark P (Sr VP Finance & Admi) | Sale | 100,000 | 21.35 | 2,135,000 |
| 2005-12-27 | Colonnese Mark P (Sr VP Finance & Admi) | Option Ex | 100,000 | .33 | 33,000 |
| 2005-10-27 | Barakett Timothy R (10% Owner) | Buy | 30,000 | 15.27 | 458,100 |
| 2005-10-24 | Barakett Timothy R (10% Owner) | Buy | 50,000 | 15.30 | 765,000 |
| 2005-10-21 | Barakett Timothy R (10% Owner) | Buy | 80,000 | 15.36 | 1,228,400 |
| 2005-10-17 | Barakett Timothy R (10% Owner) | Buy | 90,000 | 15.95 | 1,435,500 |
| 2005-06-14 | Barakett Timothy R (10% Owner) | Buy | 50,000 | 16.32 | 816,000 |
| 2005-06-10 | Barakett Timothy R (10% Owner) | Buy | 50,000 | 16.44 | 822,000 |
| 2005-06-09 | Barakett Timothy R (10% Owner) | Buy | 100,000 | 15.59 | 1,558,500 |
| 2005-05-27 | Barakett Timothy R (10% Owner) | Buy | 50,000 | 14.63 | 731,500 |
| 2005-05-25 | Barakett Timothy R (10% Owner) | Buy | 100,000 | 14.79 | 1,479,500 |
| 2005-05-18 | Barakett Timothy R (10% Owner) | Buy | 49,900 | 14.63 | 730,037 |
| 2005-05-06 | Barakett Timothy R (10% Owner) | Buy | 100,000 | 13.69 | 1,369,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Atherogenics Inc (symbol AGIX, CIK number 1107601) see the Securities and Exchange Commission (SEC) website.